VEGFA and Chorioretinal atrophy: The cumulative probabilities of mCNV-MA of 24.5% at 3 years and 37.3% at 5 years after initiation of anti-VEGF treatment in this study are also similar to the results of recent studies on chorioretinal atrophy after mCNV treated with anti-VEGF.